Session Type
Meeting
Search Results for hospitalizations
Abstract Number: 6
SHM Converge 2021
Background: Outcomes among hospitalized patients with severe vision impairment or blindness have not been extensively explored. The purpose of this study was to determine clinical and resource utilization outcomes in patients with severe vision impairment/blindness. Methods: This was a retrospective cohort study. Using the Nationwide Inpatient Sample for year 2017, hospitalized adults with and without […]
Abstract Number: 84
SHM Converge 2021
Background: It is not known whether hospital outcomes are different among patients with deafness/mutism compared to those without this disability. The purpose of this study was to assess clinical outcomes and utilization data among patients with deafness/mutism compared to all other patients. Methods: This was a retrospective cohort study. Nationwide Inpatient Sample year 2017, hospitalized […]
Abstract Number: 109
SHM Converge 2021
Background: A primary characteristic of Herpes Simplex Virus (HSV) infections is its ability to remain latent in sensory neurons and reactivate later in life. Symptoms of HSV typically present at or near the point of entry. Each of the HSV subtypes is distinguishable from one another via their mode of transmission in addition to symptoms. […]
Abstract Number: 116
Hospital Medicine 2016, March 6-9, San Diego, Calif.
Background: End Stage Renal Disease carries a poor prognosis. Only half of dialysis patients are still alive three years after the initiation of renal replacement therapy. Furthermore, dialysis patients are hospitalized more often compared to the general population, averaging two admissions per year. We hypothesized that outcomes in dialysis patients are worse when they require […]
Abstract Number: 125
Hospital Medicine 2018; April 8-11; Orlando, Fla.
Background: Patients with diabetic foot ulcers (DFUs) experience large burdens of morbidity, mortality, and hospital costs. Over a third of patients with diabetes will develop DFUs in their lifetime; and almost half of these patients subsequently develop diabetic foot infections (DFIs). Although it has been reported that obese patients with diabetes do not have higher […]
Abstract Number: 128
Hospital Medicine 2017, May 1-4, 2017; Las Vegas, Nev.
Background: Increased asthma and obesity prevalence are independently associated with health disparities. This study sought to examine the relationship between these two conditions, particularly within the pediatric population at a major inner city teaching hospital. Methods: Patients aged 3 to 18 with a diagnosis of bronchial asthma and at least one hospital encounter for an […]
Abstract Number: 152
Hospital Medicine 2018; April 8-11; Orlando, Fla.
Background: Cost-related medication non-adherence (CRN) is a persistent and serious challenge among the elderly population in the US. For elderly patients with limited economic means at increased risk of hospitalization, CRN may elevate the risk of repeated hospitalizations and emergency department visits, and lead patients into a downward spiral of worse heath and higher non-adherence. […]
Abstract Number: 165
Hospital Medicine 2020, Virtual Competition
Background: Palliative care in seriously ill patients has been shown in some studies to improve satisfaction, symptoms, inpatient mortality rates, healthcare utilization and cost. While inpatient palliative care has been shown to improve symptoms and quality of life measures, the literature on its association with 30-day readmissions have been mixed for heart failure hospitalizations. We […]
Abstract Number: 213
Hospital Medicine 2020, Virtual Competition
Background: Agency of Healthcare Research and Quality reported an increase in Opioid-related hospitalizations from 2005 to 2014. Previous studies in patients undergoing surgery have shown an increased risk of readmission with opioid dependence. This study was intended to identify the all-cause 7 and 30-day readmission rates of hospitalizations with opioid-related disorders, and potential predictors of […]
Abstract Number: 214
Hospital Medicine 2020, Virtual Competition
Background: Until the advent of novel oral anticoagulants (NOACs), Warfarin was the only oral agent available for the treatment of deep venous thrombosis (DVT) and Pulmonary embolism (PE). Bridging with parenteral anticoagulation until warfarin reaches a full therapeutic level often results in prolonged hospitalization. Rivaroxaban, Dabigatran, Apixaban, Edoxaban were approved by the FDA for DVT […]